Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Crowther

Showing results (181-190 of 282) with videos related to

Pageof 29
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphomaC Straka, R Pettengell, A Pielmeier, et al.
British Journal of Cancer|March 1, 1994
Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical featuresJ Renninson, B W Baker, A T McGown, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 8, 1998
High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction techniqueP Khan, A T McGown, M J Dawson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.
Ciba Foundation Symposium|January 1, 1990
Growth factor-assisted chemotherapy--the Manchester experienceD Crowther, J H Scarffe, A Howell, et al.
Lancet (London, England)|May 8, 1982
11-week course of sequential methotrexate, thoracic irradiation, and moderate-dose cyclophosphamide for "limited"-stage small-cell bronchogenic carcinoma. A study from the Manchester Lung Tumour GroupN Thatcher, P V Barber, R D Hunter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseaseN Thatcher, H Sharma, R Harrison, et al.
British Journal of Cancer|August 1, 1992
Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantationS M Lee, D Crowther, J H Scarffe, et al.
Hematological Oncology|April 1, 1986
Factors affecting remission and survival in patients with advanced Hodgkin's disease treated with MVPPJ Wagstaff, W Steward, M Jones, et al.
Clinical Radiology|September 1, 1985
The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: a report from the Manchester Lymphoma GroupH Anderson, J P Jenkins, D J Brigg, et al.
Pageof 29

Showing results (181-190 of 282) with videos related to

Sort By:
Pageof 29
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphomaC Straka, R Pettengell, A Pielmeier, et al.
British Journal of Cancer|March 1, 1994
Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical featuresJ Renninson, B W Baker, A T McGown, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 8, 1998
High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction techniqueP Khan, A T McGown, M J Dawson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.
Ciba Foundation Symposium|January 1, 1990
Growth factor-assisted chemotherapy--the Manchester experienceD Crowther, J H Scarffe, A Howell, et al.
Lancet (London, England)|May 8, 1982
11-week course of sequential methotrexate, thoracic irradiation, and moderate-dose cyclophosphamide for "limited"-stage small-cell bronchogenic carcinoma. A study from the Manchester Lung Tumour GroupN Thatcher, P V Barber, R D Hunter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseaseN Thatcher, H Sharma, R Harrison, et al.
British Journal of Cancer|August 1, 1992
Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantationS M Lee, D Crowther, J H Scarffe, et al.
Hematological Oncology|April 1, 1986
Factors affecting remission and survival in patients with advanced Hodgkin's disease treated with MVPPJ Wagstaff, W Steward, M Jones, et al.
Clinical Radiology|September 1, 1985
The prognostic significance of mediastinal bulk in patients with stage IA-IVB Hodgkin's disease: a report from the Manchester Lymphoma GroupH Anderson, J P Jenkins, D J Brigg, et al.
Pageof 29